EUVIMEDEUVIMED entdecken
Crossref

A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience

Merve Gozde Sezgin, Hicran Bektas

Transplant Immunology · 2023

DOI: 10.1016/j.trim.2023.101855 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2023. Verfasst von Merve Gozde Sezgin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Akdeniz University Faculty of Nursing, Department of Internal Medicine Nursing, Antalya, Turkey. Electronic address: gozdesezgin1990@gmail.com. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Lymphoma, Graft vs Host Disease, Febrile Neutropenia. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Early evaluation of symptoms and taking appropriate preventive measures can improve outcomes for patients with lymphoma undergoing hematopoietic stem cell transplantation (HSCT). This study aimed to examine the treatment and outcomes of patients with lymphoma undergoing HSCT. METHODS: Patients with lymphoma undergoing SCT at a university hospital between 15.06.2018 and 15.06.2020, were selected for a retrospective study. The medical treatments of patients were obtained from the records on the Hospital Information Management System (HIMS) database. The study was reported following the STROBE checklist. RESULTS: Sixty-four patients were analyzed. The mean age of the patients was 48.25 ± 16.93 (p = 0.76). Although relapse developed in 26 (40.6%) patients with lymphoma, remission was achieved in 38 (59.4%) patients. The incidence of skin graft-versus-host disease (GVHD) symptoms in patients with relapse [14(53.8%)] was found to be significantly higher than in patients in remission [4(10.5%)] (p < 0.001). The most common symptoms seen in patients undergoing HSCT were oral mucositis (78.1%), febrile neutropenia (68.8%), and anemia (56.3%). In the treatments applied after SCT, the administration of antifungal (p = 0.033), analgesic (p = 0.001), and anticoagulant (p = 0.008) treatments to the patients who were in remission compared with the relapsed patients was significant. Less courses (OR: 0.446; 95% CI: 0.22-0.907; p = 0.026), analgesic therapy (OR:6.22; 95% CI: 1.61-24.027; p = 0.008), and anticoagulant treatment (OR:7.13; %) 95 CI: 1.374-37.1; p = 0.019) were found to increase the risk of relapse. Because of the increase in the number of cures in SCT, the incidence of diarrhea (p = 0.016) and GIS GVHD (p = 0.022) was high. It was determined that the hospitalization period was shorter in patients with febrile neutropenia (p = 0.021), thrombocytopenia/bleeding (p = 0.031), and secretion (p = 0.036) symptoms. CONCLUSIONS: Patients experienced severe symptoms such as oral mucositis, febrile neutropenia, and anemia due to HSCT, and necessary treatment was applied for the symptoms. Further clinical studies must determine the symptoms and patient outcomes associated with SCT. It is predicted that patients will benefit from regular follow-up of their symptoms and planning of appropriate evidence-based nursing interventions and that this will improve the quality of care to be offered to them and increase their life span.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLymphomaGraft vs Host DiseaseFebrile NeutropeniaHumansRetrospective StudiesNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

LymphomaNursingPatient outcomesRetrospective studyStem cell transplantationTreatment

Autor:innen und Institutionen

  • Akdeniz University Faculty of Nursing, Department of Internal Medicine Nursing, Antalya, Turkey. Electronic address: gozdesezgin1990@gmail.com.
  • Akdeniz University Faculty of Nursing, Department of Internal Medicine Nursing, Antalya, Turkey. Electronic address: hbaydin@akdeniz.edu.tr.

Zitieren

APA

Sezgin, M. G., & Bektas, H. (2023). A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience. Transplant Immunology. https://doi.org/10.1016/j.trim.2023.101855

Vancouver

Sezgin MG, Bektas H. A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience. Transplant Immunology. 2023. doi:10.1016/j.trim.2023.101855

BibTeX
@article{Sezgin2023,
  author = {Sezgin, Merve Gozde and Bektas, Hicran},
  title = {A retrospective study of treatment and outcomes of patients with lymphoma undergoing hematopoietic stem cell transplantation: A single-center experience},
  journal = {Transplant Immunology},
  year = {2023},
  doi = {10.1016/j.trim.2023.101855}
}
Kostenlos starten →